| Literature DB >> 28554415 |
Anna Sauerbier1, Ilaria Cova2, Miguel Rosa-Grilo3, Raquel N Taddei3, Laurie K Mischley4, K Ray Chaudhuri5.
Abstract
Nonmotor symptoms (NMS) are integral to Parkinson's disease (PD) and the management can often be challenging. In spite of the growing evidence that NMS have a key impact on the quality of life of patients and caregivers, most clinical trials still focus on motor symptoms as primary outcomes. As a consequence strong evidence-based treatment recommendations for NMS occurring in PD are spare. In this chapter, the current data addressing the treatment of major NMS such as sleep, cognitive and autonomic dysfunction, and depression and anxiety are described.Entities:
Keywords: Nonmotor symptoms; Parkinson's disease; Treatment
Mesh:
Year: 2017 PMID: 28554415 DOI: 10.1016/bs.irn.2017.03.002
Source DB: PubMed Journal: Int Rev Neurobiol ISSN: 0074-7742 Impact factor: 3.230